Mechanical cues as immunomodulators in neuroinflammation-driven spinal sensitization: analgesic mechanisms and therapeutic strategies - Report - MDSpire

Mechanical cues as immunomodulators in neuroinflammation-driven spinal sensitization: analgesic mechanisms and therapeutic strategies

  • By

  • Li-ya Tang

  • Ke-shang Li

  • Xiao-xia Kuang

  • Jiang-shan Li

  • Xiang Feng

  • Wu Li

  • April 30, 2026

  • 0 min

Share

Mechanical Signals as Modulators of Immunity in Neuroinflammation-Induced Spinal Sensitization

Overview

This report discusses how mechanical interventions can modulate neuroinflammation and spinal sensitization, potentially offering non-pharmacological pain relief strategies. It highlights the need for a mechanobiological framework to better understand these interactions and improve treatment protocols.

Background

Chronic pain affects approximately 30% of the global population, often leading to significant functional limitations and reduced quality of life. Current pain management strategies heavily rely on pharmacological treatments, which can have limited efficacy and adverse effects. Understanding the role of neuroinflammation in chronic pain is crucial for developing effective non-pharmacological interventions.

Data Highlights

No numerical data provided in the article.

Key Findings

  • Neuroinflammation is a key driver of spinal sensitization and chronic pain.
  • Mechanical stimuli, such as tuina, can modulate glial activation and inflammatory signaling.
  • There is a need for standardized mechanical dosing and mechanism-informed biomarkers for effective treatment.
  • Mechanical interventions may enhance perfusion and metabolic homeostasis in the spinal microenvironment.
  • Current clinical practices often overlook the potential of non-pharmacological analgesia.

Clinical Implications

Healthcare professionals should consider integrating mechanical interventions into chronic pain management protocols. A mechanobiological approach may provide insights into personalized treatment strategies that address neuroinflammation and spinal sensitization.

Conclusion

Mechanical signals have the potential to serve as immunomodulatory cues in the treatment of chronic pain. Further research is needed to establish standardized protocols and biomarkers for clinical application.

References

  1. Wong et al., Brain, 2023 -- Targeting spinal mechanistic target of rapamycin complex 2 alleviates inflammatory and neuropathic pain
  2. Brain, 2023 -- Differential Functions of mTORC2 in Excitatory and Inhibitory Neurons During Inflammatory and Neuropathic Pain
  3. Brain, 2023 -- Inhibition of spinal mTORC2 signaling reduces inflammatory and neuropathic pain symptoms
  4. Clinical Rheumatology, 2023 -- Understanding Central Sensitization: A Biopsychosocial Perspective on Chronic Widespread Pain in Fibromyalgia and Chronic Fatigue Syndrome Patients
  5. Pain Medicine, 2023 -- Noninvasive brain stimulation beyond the motor cortex: a systematic review and meta-analysis exploring effects on quantitative sensory testing in clinical pain
  6. BMJ Evidence-Based Medicine, 2025 -- Analgesic effects of non-surgical and non-interventional treatments for low back pain: a systematic review and meta-analysis of placebo-controlled randomised trials
  7. Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis
  8. Manual therapy and exercise effects on inflammatory cytokines: a narrative overview
  9. Analgesic effects of non-surgical and non-interventional treatments for low back pain: a systematic review and meta-analysis of placebo-controlled randomised trials | BMJ Evidence-Based Medicine

Original Source(s)

Related Content